Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor β-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells

Molecular and Cellular Biology

Volumn 28, Issue 12, 2008, Pages 4142-4151

  Miller, Anna V ^a   Alvarez, Sergio E ^a   Spiegel, Sarah ^a   Lebman, Deborah A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD3 PROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; DISEASE COURSE; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; TUMOR PROMOTION;

CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DISEASE PROGRESSION; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOPHOSPHOLIPIDS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 44949233776     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01465-07     Document Type: Article

References (50)

1. Akhurst, R. J., and R. Derynck. 2001. TGF-beta signaling in cancer: a double-edged sword. Trends Cell Biol. 11:S44-S51.
2. Bakin, A. V., C. Rinehart, A. K. Tomlinson, and C. L. Arteaga. 2002. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115:3193-3206.
3. Bakin, A. V., A. K. Tomlinson, N. A. Bhowmiek, H. L. Moses, and C. L. Arteaga. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:36803-36810.
4. Bhowmick, N. A., R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses. 2001. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276: 46707-46713.
5. Davies, M., M. Robinson, E. Smith, S. Huntley, S. Prime, and I. Paterson. 2005. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell Biochem. 95:918-931.
6. Davis, M. D., J. J. Clemens, T. L. Macdonald, and K. R. Lynch. 2005. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 280:9833-9841.
7. de Caestecker, M. P., E. Piek, and A. B. Roberts. 2000. Role of transforming growth factor-beta signaling in cancer. J. Natl. Cancer Inst. 92:1388-1402.
8. Edmiston, J. S., W. A. Yeudall, T. D. Chung, and D. A. Lehman. 2005. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Cancer Res. 65:4782-4788.
9. Edsall, L. C., and S. Spiegel. 1999. Enzymatic measurement of sphingosine 1-phosphate. Anal. Biochem. 272:80-86.
10. Edsall, L. C., J. R. Van Brocklyn, O. Cuvillier, B. Kleuser, and S. Spiegel. 1998. N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37:12892-12898.
11. English, D., Z. Welch, A. T. Kovala, K. Harvey, O. V. Volpert, D. N. Brindley, and J. G. Garcia. 2000. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14:2255-2265.
12. Gonda, K., H. Okamoto, N. Takuwa, Y. Yatomi, H. Okazaki, T. Sakurai, S. Kimura, R. Sillard, K. Harii, and Y. Takuwa. 1999. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem. J. 337:67-75.
13. Goparaju, S. K., P. S. Jolly, K. R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, and S. Spiegel. 2005. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 25:4237-4249.
14. Hait, N. C., A. Bellamy, S. Milstien, T. Kordula, and S. Spiegel. 2007. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282:12058-12065.
15. Hait, N. C., C. A. Oskeritzian, S. W. Paugh, S. Milstien, and S. Spiegel. 2006. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758:2016-2026.
16. Hait, N. C., S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel. 2005. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J. Biol. Chem. 280:29462-29469.
17. Hanafusa, H., J. Ninomiya-Tsuji, N. Masuyama, M. Nishita, J. Fujisawa, H. Shibuya, K. Matsumoto, and E. Nishida. 1999. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J. Biol. Chem. 274:27161-27167.
18. Hartsough, M. T., and K. M. Mulder. 1995. Transforming growth factor beta activation of p44 mapk in proliferating cultures of epithelial cells. J. Biol. Chem. 270:7117-7124.
19. Holmes, R. S., and T. L. Vaughan. 2007. Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol. 17:2-9.
20. Javelaud, D., and A. Mauviel. 2005. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24:5742-5750.
21. Keller, C. D., G. P. Rivera, M. Tolle, M. van der Giet, J. Chun, H. H. Radeke, M. Schafer-Korting, and B. Kleuser. 2007. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am. J. Pathol. 170:281-292.
22. Kono, Y., T. Nishiuma, Y. Nishimura, Y. Kotani, T. Okada, S. I. Nakamura, and M. Yokoyama. 2007. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF{beta}1. Am. J. Respir. Cell Mol. Biol. 397:395-404.
23. Kwak, H. J., M. J. Park, H. Cho, C. M. Park, S. I. Moon, H. C. Lee, I. C. Park, M. S. Kim, C. H. Rhee, and S. I. Hong. 2006. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol. Cancer Res. 4:209-220.
24. Lebman, D. A., J. S. Edmiston, T. D. Chung, and S. R. Snyder. 2002. Heterogeneity in the transforming growth factor beta response of esophageal cancer cells. Int. J. Oncol. 20:1241-1246.
25. Lee, M. K., C. Pardoux, M. C. Hall, P. S. Lee, D. Warburton, J. Qing, S. M. Smith, and R. Derynck. 2007. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26:3957-3967.
26. Lee, O. H., Y. M. Kim, Y. M. Lee, E. J. Moon, D. J. Lee, J. H. Kim, K. W. Kim, and Y. G. Kwon. 1999. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264:743-750.
27. Levy, L., M. Howell, D. Das, S. Harkin, V. Episkopou, and C. S. Hill. 2007. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol. Cell. Biol. 27:6068-6083.
28. Liu, H., M. Sugiura, V. E. Nava, L. C. Edsall, K. Kono, S. Poulton, S. Milstien, T. Kohama, and S. Spiegel. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275:19513-19520.
29. Massague, J., and Y. G. Chen. 2000. Controlling TGF-beta signaling. Genes Dev. 14:627-644.
30. Matsuura, I., N. G. Denissova, G. Wang, D. He, J. Long, and F. Liu. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226-231.
31. Osada, M., Y. Yatomi, T. Ohmori, H. Ikeda, and Y. Ozaki. 2002. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun. 299:483-487.
32. Pitson, S. M., P. A. Moretti, J. R. Zebol, H. E. Lynn, P. Xia, M. A. Vadas, and B. W. Wattenberg. 2003. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22:5491-5500.
33. Radeke, H. H., H. von Wenckstern, K. Stoidtner, B. Sauer, S. Hammer, and B. Kleuser. 2005. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J. Immunol. 174:2778-2786.
34. Roberts, A. B., and L. M. Wakefield. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100:8621-8623.
35. Rockett, J. C., K. Larkin, S. J. Darnton, A. G. Morris, and H. R. Matthews. 1997. Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br. J. Cancer 75:258-263.
36. Sauer, B., R. Vogler, H. von Wenckstern, M. Fujii, M. B. Anzano, A. B. Glick, M. Schafer-Korting, A. B. Roberts, and B. Kleuser. 2004. Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J. Biol. Chem. 279:38471-38479.
37. Siewert, J. R., and K. Ott. 2007. Are squamous and adenocarcinomas of the esophagus the same disease? Semin. Radiat. Oncol. 17:38-44.
38. Sowa, H., H. Kaji, T. Yamaguchi, T. Sugimoto, and K. Chihara. 2002. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol. Chem. 277:36024- 36031.
39. Spiegel, S., and S. Milstien. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4:397-407.
40. i pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol. Cell. Biol. 23:1534-1545.
41. Wang, F., J. R. Van Brocklyn, J. P. Hobson, S. Movafagh, Z. Zukowska-Grojec, S. Milstien, and S. Spiegel. 1999. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274:35343-35350.
42. Watanabe, H., M. P. de Caestecker, and Y. Yamada. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J. Biol. Chem. 276:14466-14473.
43. Windh, R. T., M. J. Lee, T. Hla, S. An, A. J. Barr, and D. R. Manning. 1999. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J. Biol. Chem. 274:27351-27358.
44. Xie, L., B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakre, and H. L. Moses. 2004. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6:603-610.
45. Xin, C., S. Ren, B. Kleuser, S. Shabahang, W. Eberhardt, H. Radeke, M. Schafer-Korting, J. Pfeilschifter, and A. Huwiler. 2004. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J. Biol. Chem. 279:35255- 35262.
46. Yacoub, A., W. Hawkins, D. Hanna, H. Young, M. A. Park, M. Grant, J. D. Roberts, D. T. Curiel, P. B. Fisher, K. Valerie, S. Grant, M. P. Hagan, and P. Dent. 2007. Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment. Mol. Pharmacol. 71:259-275.
47. Yamanaka, M., D. Shegogue, H. Pei, S. Bu, A. Bielawska, J. Bielawski, B. Pettus, Y. A. Hannun, L. Obeid, and M. Trojanowska. 2004. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. J. Biol. Chem. 279:53994-54001.
48. Yoo, J., M. Ghiassi, L. Jirmanova, A. G. Balliet, B. Hoffman, A. J. Fornace, Jr., D. A. Liebermann, E. P. Bottinger, and A. B. Roberts. 2003. Transforming growth factor-beta-induced apoptosis is mediated by Smad-depcndent expression of GADD45b through p38 activation. J. Biol. Chem. 278:43001-43007.
49. Young, N., and J. R. Van Brocklyn. 2007. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Exp. Cell Res. 313:1615-1627.
50. Zavadil, J., M. Bitzer, D. Liang, Y. C. Yang, A. Massimi, S. Kneitz, E. Piek, and E. P. Bottinger. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. USA 98:6686-6691.